Press Archives
Researchers at the George Washington University found that the majority of dermatology patients were comfortable with virtual visits as an alternative to in-person appointments.
While COVID-19 infected patients should be treated with standard anticoagulation therapies, such as blood thinning medication, a new study by researchers at the George Washington University shows that anticoagulating patients at higher doses, without traditional medical indications to do so, may be ineffective and even harmful.
Third-year MD student King John Pascual and mentor Ali Pourmand, MD, from SMHS are presenting findings at the American College of Emergency Physicians on the role of Google searches during the early phase of the pandemic in the U.S.
The George Washington University, in partnership with several community organizations, is providing free flu shots to people living in Ward 7 and Ward 8 and other medically underserved parts of Washington, D.C.
The National Institutes of Health has awarded $1.6 million to researchers at SMHS for research on hormonal control of HIV latency.
Building on its widely recognized KastleSafeSpaces health safety and security platform, Kastle Systems announced today it is partnering with a multidisciplinary team from GW to provide safe and efficient returns to the workplace for their tenants and clients in the wake of the coronavirus pandemic.
The retrospective study from a team at GW found that spironolactone may be safe to treat female pattern hair loss in breast cancer survivors.
Investigators at SMHS received a $1.2 million grant from Wellcome Trust to produce a controlled human hookworm infection model and establish a hookworm vaccine challenge model for two of the most advanced hookworm vaccine candidate antigens in endemic areas.
